PatientsLikeMe ™

all
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Maxalt, Maxalt MLT
Generic Name: Rizatriptan

What is Rizatriptan? Rizatriptan is an antimigraine agent available under the brand names Maxalt-MLT®; Maxalt®. It is used in the treatment of acute treatment of migraine with or without aura.

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

31 patients in the community are taking or have taken Rizatriptan.

Reason # Patients Percentage of patients
Other 18 58%
Headache 3 9%
Headaches 2 6%
Pain 2 6%
Migraines 2 6%
migraine pain 1 3%
migraine headaches 1 3%

Dosages

Based on the patients currently taking Rizatriptan.

  0 mg none 0 none
  21 Number of Patients: 21 2 Number of Patients: 2  

Duration

How long current patients have been taking Rizatriptan or how long patients were taking Rizatriptan before stopping.

Currently taking Rizatriptan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
6
1
1
14

Stopped taking Rizatriptan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
0
0
2
Why Patients Stopped Taking Rizatriptan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2 40% Did not seem to work: 40%
Doctor's advice 1 20% Doctor's advice: 20%
Side effects too severe 1 20% Side effects too severe: 20%
Other 1 20% Other: 20%
Not indicated 1 20% Not indicated: 20%

Patient Reported Evaluations

Results from 7 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 67% 2
Slight 33% 1

Other

Side-effects (as an overall problem)

Severe 0% 0
Moderate 14% 1
Mild 29% 2
None 57% 4

Top reported side-effects include: Tingling in face, tiredness, Drowsiness

Summary results are based on 7 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 7)

  • mountabora
    Depression: 0
    Emotional: 0
    Compulsion: 0
    Anxiety: 0
    Mania: 0
    Physical: 0
    External Stress: Moderate
    24 F
    Function: High
    Distress: Low
  • mountabora
  • by mountabora
    Aug 18, 2008
  • EfficacyMajor
  • Side-effectsMild
  • Headaches

  • EfficacySlight
  • Side-effectsNone
  • Other

See all evaluation results for Rizatriptan



Back to top